Demand Generation for MedTech Companies
Demand generation for MedTech companies is the set of commercial activities that move a medical technology from clinical validation and early adopter use into reproducible pipeline identifying health system and provider organisation accounts, building multi-stakeholder engagement across clinical, procurement, IT, and administrative buyers, and converting clinical champions into commercially supported purchasing decisions. Unlike most B2B demand gen, MedTech demand gen operates at the intersection of clinical evidence, health economics, procurement processes, and regulatory compliance each of which creates a distinct set of buyer concerns that must be addressed simultaneously.
The MedTech Buying Journey: 4 Stakeholders Who All Have to Say Yes
MedTech purchases at integrated delivery networks (IDNs), health systems, and hospital groups are among the most complex B2B buying decisions in any industry. For a clinical technology to move from a physician’s interest to a purchase order, it typically needs approval from four distinct stakeholder groups, each with fundamentally different concerns.
| Stakeholder | Primary Concern | Evidence They Need | Content Format |
|---|---|---|---|
| Clinical Champion (Physician/Clinician) | Clinical outcomes, patient benefit, workflow fit | Clinical trial data, peer-reviewed publications, comparative effectiveness data | Clinical abstracts, peer comparison studies, reference site information |
| Procurement/Value Analysis Committee | Total cost, contract terms, supplier qualification, utilisation | Health economics models, CPT/DRG reimbursement data, supply chain documentation | Economic value analysis, reimbursement guide, procurement documentation |
| C-Suite/CFO | Capital expenditure justification, ROI, strategic fit | Business case with ROI timeline, benchmark data from similar institutions | Executive summary, financial model, peer institution case studies |
| IT/Biomedical Engineering | EHR integration, cybersecurity, maintenance, interoperability | Technical integration specifications, cybersecurity documentation, interoperability standards | Technical integration guide, security whitepaper, implementation protocol |
Demand generation that only activates the clinical champion will generate interest that cannot convert to commercial pipeline. True MedTech demand gen builds multi-stakeholder engagement from the start or at minimum, equips the clinical champion with the materials to build internal support across all four stakeholder groups.
MedTech deals where marketing equips the clinical champion with procurement and economic materials close 55% faster
Health Economics Content: The Missing Link in MedTech Demand Gen
The single most consistent gap in MedTech marketing is health economics content. Most MedTech companies produce excellent clinical content publications, clinical data summaries, case studies from clinical champions. But when those champions take the technology to their procurement or value analysis committee, they often face questions they cannot answer: What is the CPT reimbursement rate? What does this cost per procedure compared to current standard of care? What is the financial impact on the hospital’s DRG economics?
Health economics content bridges this gap. It translates clinical benefit into economic terms that procurement and finance stakeholders can evaluate. A health economics model that shows a cardiac monitoring device reduces ICU length of stay by 1.2 days, saving $3,400 per patient encounter, converts a clinical interest conversation into a financial business case.
Build health economics content for every primary indication. Make it downloadable, make it personalised by institution type (academic medical centre, community hospital, ASC), and make it available to clinical champions to share with their internal stakeholders.
IDN and GPO Strategy in MedTech Demand Gen
Integrated delivery networks (IDNs) and group purchasing organisations (GPOs) control a significant portion of hospital procurement. For MedTech companies, these entities create both an opportunity and a complication.
GPO contracting can dramatically accelerate hospital procurement for products that match an existing GPO contract. But GPO contracts also mean that products not on contract face additional barriers to purchase regardless of clinical merit.
- Pursue GPO contracting early: For MedTech companies at commercial scale, GPO contracting should be part of the commercial strategy, not an afterthought. Being on a major GPO’s formulary significantly reduces procurement friction.
- Identify IDN centres of excellence: Large IDNs have centres of excellence for specific clinical areas. Getting a strong clinical champion at a centre of excellence creates replication potential across the system.
- Build IDN-level case studies: IDN administrators respond to evidence from peer institutions of similar size and complexity. A case study from an IDN of comparable scale carries more weight than data from a single community hospital.
Digital Demand Gen for MedTech: What Works
| Channel | What Works | What Doesn’t |
|---|---|---|
| Targeting by job function (clinical, procurement, health system leadership) + clinical content | Generic medical device advertising without clinical specificity | |
| Medical society journals and publications | Clinical data dissemination, peer-reviewed publication citations | Awareness ads without clinical evidence anchor |
| Conference presence (HIMSS, ACC, AHA, etc.) | ABM pre-conference outreach + structured meeting agenda | Passive booth presence without targeted account engagement |
| Email nurture | Segmented sequences by stakeholder type (clinical vs. economic) | Single-track nurture that ignores stakeholder role |
| Webinars and virtual CME | Peer-to-peer clinical evidence presentations | Vendor-led product demos disguised as educational content |
About The Smarketers
The Smarketers is India’s first ITSMA-awarded ABM agency and a HubSpot Gold Partner. With 40+ implemented ABM programs and an 85% success rate, they work with B2B technology companies, IT services firms, and life sciences companies to drive pipeline through ABM, demand generation, and RevOps.
Frequently Asked Questions
What is demand generation for MedTech companies?
MedTech demand generation is the commercial function that builds pipeline by engaging all stakeholders involved in healthcare technology purchasing clinical champions, procurement/value analysis committees, C-suite, and IT/biomedical engineering. It combines clinical evidence dissemination, health economics content, IDN and GPO strategy, and multi-channel digital engagement to move technology from clinical interest to commercial purchasing decision.
Why is MedTech demand gen different from standard B2B?
MedTech operates at the intersection of clinical evidence, health economics, procurement regulation, and IT integration. Unlike standard B2B demand gen, which focuses primarily on business or technical decision-makers, MedTech must simultaneously serve clinical, economic, operational, and regulatory concerns often in a procurement environment constrained by GPO contracts, capital equipment committee approvals, and clinical privilege requirements.
What is health economics content and why does it matter for MedTech?
Health economics content translates clinical benefit into economic terms that procurement and finance stakeholders can evaluate cost per procedure, reimbursement rates, impact on hospital DRG economics, length of stay reduction value. This content bridges the gap between clinical champion interest and procurement approval by giving clinicians the economic language they need to build internal business cases.
How do IDN and GPO strategies affect MedTech demand generation?
IDNs control purchasing for large health systems and prefer standardised contract vehicles. GPOs aggregate purchasing power and create contract formularies that influence hospital procurement decisions. MedTech companies that are not on relevant GPO contracts face significant procurement barriers regardless of clinical merit. Building an IDN and GPO commercial strategy alongside clinical demand gen is essential for scaling a MedTech commercial programme.
